Related Experiment Videos
A therapeutic vaccine for mucosal candidiasis
1Discipline of Immunology and Microbiology, Faculty of Medicine and Health Sciences, University of Newcastle, NSW 2308, Newcastle, Australia.
Vaccine
|March 21, 2001
Summary
Oral immunization with Candida albicans blastospores in mice induced clinical immunity. This strategy promoted sustained production of key cytokines, indicating an effective T cell response against fungal infections.
Area of Science:
- Immunology
- Microbiology
- Vaccinology
Background:
- Recurrent mucosal Candida albicans infections pose significant clinical challenges.
- Current prophylactic and therapeutic vaccines for Candida infections are lacking.
Purpose of the Study:
- To determine an optimal immunization strategy against oral Candida albicans infection using a mouse model.
- To identify regulatory and effector molecules of T cell activation as indicators of induced immunity.
Main Methods:
- Development and utilization of a mouse model for oral Candida infection.
- Comparison of oral versus subcutaneous immunization routes using the blastospore yeast form.
- Analysis of T cell cytokine responses (IFN-gamma, IL-4) from antigen-stimulated lymphocytes.
Main Results:
- Oral immunization, but not subcutaneous, conferred clinical immunity.
- Oral immunization induced a shift in cytokine response parameters.
- Early and sustained production of Interferon-gamma (IFN-gamma) and Interleukin-4 (IL-4) was observed.
Conclusions:
- Oral immunization with Candida albicans blastospores is an effective strategy for inducing protective immunity.
- Induced immunity is characterized by a balanced T cell cytokine response, including both IFN-gamma and IL-4.